Actavis Enters U.S. Generic Market Through $500 Mil. Amide Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Iceland-based Actavis will diversify its European-centric revenue base through the acquisition of Amide, located in New Jersey. An Amide manufacturing site currently under construction and slated for completion in 2006 could significantly boost U.S. capacity for the combined companies.